P2Y受体：治疗溃疡性结肠炎的新靶点。 - Suppr

P2Y receptors: a new target for treating ulcerative colitis.

作者信息

Zuo Yan-Qin, Tang Yong

机构信息

School of Acupuncture and Tuina/International Joint Research Centre On Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.

Acupuncture and Chronobiology Key Laboratory of Sichuan Province, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.

出版信息

Purinergic Signal. 2024 May 9. doi: 10.1007/s11302-024-10017-y.

DOI:10.1007/s11302-024-10017-y

PMID:38722454

Abstract

摘要

相似文献

P2Y receptors: a new target for treating ulcerative colitis.

Purinergic Signal. 2024 May 9. doi: 10.1007/s11302-024-10017-y.

Targeting P2YR protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis.

Nat Commun. 2024 Mar 7;15(1):2083. doi: 10.1038/s41467-024-46365-x.

The UDP-glucose/P2Y14 receptor axis promotes eosinophil-dependent large intestinal inflammation.

Int Immunol. 2024 Mar 9;36(4):155-166. doi: 10.1093/intimm/dxad050.

Functional characterization of purinergic receptor P2Y in the Japanese flounder (Paralichthys olivaceus) head kidney macrophages.

Fish Shellfish Immunol. 2019 Oct;93:200-207. doi: 10.1016/j.fsi.2019.07.053. Epub 2019 Jul 18.

Recent progress on the discovery of P2Y receptor antagonists.

Eur J Med Chem. 2019 Aug 1;175:34-39. doi: 10.1016/j.ejmech.2019.04.068. Epub 2019 Apr 29.

P2Y receptor in trigeminal ganglion contributes to neuropathic pain in mice.

Eur J Pharmacol. 2022 Sep 15;931:175211. doi: 10.1016/j.ejphar.2022.175211. Epub 2022 Aug 15.

Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands.

Bioorg Med Chem. 2015 Jul 15;23(14):4056-64. doi: 10.1016/j.bmc.2015.03.042. Epub 2015 Mar 21.

Milk fat globule-epidermal growth factor 8 is decreased in intestinal epithelium of ulcerative colitis patients and thereby causes increased apoptosis and impaired wound healing.

Mol Med. 2012 May 9;18(1):497-506. doi: 10.2119/molmed.2011.00369.

Study on the mechanism of Huangqin Decoction on rats with ulcerative colitis of damp-heat type base on mtDNA, TLR4, p-PI3K, p-Akt protein expression and microbiota.

J Ethnopharmacol. 2022 Sep 15;295:115356. doi: 10.1016/j.jep.2022.115356. Epub 2022 May 11.

Bone Morphogenetic Protein 4 Alleviates DSS-Induced Ulcerative Colitis Through Activating Intestinal Stem Cell by Target ID3.

Front Cell Dev Biol. 2021 Oct 6;9:700864. doi: 10.3389/fcell.2021.700864. eCollection 2021.

本文引用的文献

Targeting P2YR protects against necroptosis of intestinal epithelial cells through PKA/CREB/RIPK1 axis in ulcerative colitis.

Nat Commun. 2024 Mar 7;15(1):2083. doi: 10.1038/s41467-024-46365-x.

Ulcerative colitis.

Lancet. 2023 Aug 12;402(10401):571-584. doi: 10.1016/S0140-6736(23)00966-2.

The market for ulcerative colitis.

Nat Rev Drug Discov. 2022 Jan;21(1):15-16. doi: 10.1038/d41573-021-00194-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

P2Y receptors: a new target for treating ulcerative colitis.

作者信息

Zuo Yan-Qin, Tang Yong

机构信息

School of Acupuncture and Tuina/International Joint Research Centre On Purinergic Signalling, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.

Acupuncture and Chronobiology Key Laboratory of Sichuan Province, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, China.